| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/29/2004 | WO2004113925A1 Detection of protease-resistant prion protein according to an asymmetric spontaneous interaction |
| 12/29/2004 | WO2004113924A2 Method and system for generating and capturing peptides on a target surface |
| 12/29/2004 | WO2004113923A1 Enzyme/chemical reactor based protein processing method for proteomics analysis by mass spectrometry |
| 12/29/2004 | WO2004113922A2 System and method employing photokinetic techniques in cell biology imaging applications |
| 12/29/2004 | WO2004113921A1 Reagent for assaying anti-treponema pallidum antibody and method of assaying anti-treponema pallidum antibody |
| 12/29/2004 | WO2004113920A1 Screening method for substances binding to merozoite surface protein-1/42 |
| 12/29/2004 | WO2004113919A2 Nano and micro-technology virus detection method and device |
| 12/29/2004 | WO2004113917A2 Method and reagent for producing narrow, homogenous reagent strips |
| 12/29/2004 | WO2004113916A1 Analytical test piece and process for producing the same |
| 12/29/2004 | WO2004113915A1 System and method for coding information on a biosensor test strip |
| 12/29/2004 | WO2004113914A1 System and method for coding information on a biosensor test strip |
| 12/29/2004 | WO2004113913A1 Method for analyte measurement employing maximum dosing time delay |
| 12/29/2004 | WO2004113912A1 System and method for determining a temperature during analysis of biological fluid |
| 12/29/2004 | WO2004113911A1 System and method for coding information on a biosensor test strip |
| 12/29/2004 | WO2004113910A1 Devices and methods relating to electrochemical biosensors |
| 12/29/2004 | WO2004113909A1 System and method for coding information on a biosensor test strip |
| 12/29/2004 | WO2004113908A1 Apparatus for measuring blood cell deformability |
| 12/29/2004 | WO2004113905A1 Mass analysis method and mass analysis apparatus |
| 12/29/2004 | WO2004113903A1 Analysis implement with opening in insulation film |
| 12/29/2004 | WO2004113902A1 Reagent stripe for test strip |
| 12/29/2004 | WO2004113901A1 Test strip with slot vent opening |
| 12/29/2004 | WO2004113900A2 Test strip with flared sample receiving chamber |
| 12/29/2004 | WO2004113896A2 System and method for analysis of a biological fluid by the use electrical means |
| 12/29/2004 | WO2004113895A1 High throughput microcantilever detector |
| 12/29/2004 | WO2004113894A1 Moveable transparent barrier for x-ray analysis of a pressurized sample |
| 12/29/2004 | WO2004113893A1 System, device and method for exciting a sensor and detecting analyte |
| 12/29/2004 | WO2004113877A1 Microfluidic systems for size based removal of red blood cells and platelets from blood |
| 12/29/2004 | WO2004113870A2 Time domain resolving chemical sampler using sorbent material |
| 12/29/2004 | WO2004113834A2 Method of determining a dimension of a sample of a construction material and associated appartus |
| 12/29/2004 | WO2004113689A2 Device and method for automatically monitoring the operating condition of a lubricant of a machine or machine part |
| 12/29/2004 | WO2004113678A1 Improved downhole pv tests for bubble point pressure |
| 12/29/2004 | WO2004113566A2 Disease related protein network |
| 12/29/2004 | WO2004113562A1 Method for assaying lkb1 phosphorylation activity |
| 12/29/2004 | WO2004113561A2 Methods for diagnosing, monitoring, staging and treating heart failure |
| 12/29/2004 | WO2004113559A1 Method for the decomposition and derivatization of biological samples and method for detecting bacteria in said samples |
| 12/29/2004 | WO2004113558A1 Method of screening remedy for breast cancer |
| 12/29/2004 | WO2004113556A2 Assay and kits for detecting protein binding |
| 12/29/2004 | WO2004113555A2 Identifying, monitoring, and sorting genetically modified plant portions |
| 12/29/2004 | WO2004113552A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 12/29/2004 | WO2004113533A1 LIVER X RECEPTOR α SPLICING VARIANT PROTEIN, GENE CODING FOR THE SAME AND USE THEREOF |
| 12/29/2004 | WO2004113529A1 Method of detecting reaction between dna and dna binding proteins |
| 12/29/2004 | WO2004113526A1 Method of preparing gene expression profile |
| 12/29/2004 | WO2004113515A2 Tissue modeling in embryonic stem (es) cell system |
| 12/29/2004 | WO2004113513A2 Methods and compositions for modulating stem cell growth and differentiation |
| 12/29/2004 | WO2004113503A2 Mbms as modifiers of branching morphogenesis and methods of use |
| 12/29/2004 | WO2004113500A2 B7s1: an immune modulator |
| 12/29/2004 | WO2004113229A1 Mixed metal oxides and use thereof in co2 sensors |
| 12/29/2004 | WO2004113171A2 Apparatus for packing sample powder for use in component analysis |
| 12/29/2004 | WO2004112834A1 Cancerous disease modifying antibodies |
| 12/29/2004 | WO2004112829A2 Compositions and methods for the diagnosis and treatment of tumors of glial origin |
| 12/29/2004 | WO2004112820A2 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| 12/29/2004 | WO2004112700A2 Methods and compositions for modulating amyloid precursor protein translation |
| 12/29/2004 | WO2004112698A2 Methods for obtaining anti-retroviral agents |
| 12/29/2004 | WO2004112575A2 Gene amplification and overexpression in cancer |
| 12/29/2004 | WO2004112572A2 Monitoring immunologic, hematologic and inflammatory diseases |
| 12/29/2004 | WO2004112570A2 Detection of survivin in the biological fluids of cancer patients |
| 12/29/2004 | WO2004112565A2 Diagnosis and treatment of liver, pulmonary and cardiac fibrosis |
| 12/29/2004 | WO2004112473A1 Novel animal model for epilepsy |
| 12/29/2004 | WO2004096999A3 In vitro translation system |
| 12/29/2004 | WO2004096124A3 Compositions and methods for the diagnosis and treatment of tumor |
| 12/29/2004 | WO2004093790A3 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 12/29/2004 | WO2004087049A3 Selective activation of cellular activities mediated through a common toll-like receptor |
| 12/29/2004 | WO2004086050A3 Labelling agents for mass spectrometry comprising tertiary amines |
| 12/29/2004 | WO2004085046A3 Method for selectively binding a substrate to sorbents by way of at least bivalent bonds |
| 12/29/2004 | WO2004084942A3 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 12/29/2004 | WO2004083812A3 Method and apparatus for detection of contaminants in a fluid |
| 12/29/2004 | WO2004079338A3 Methods and systems for dissolution testing |
| 12/29/2004 | WO2004078926A3 Immunologigal markers |
| 12/29/2004 | WO2004065542A3 MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 12/29/2004 | WO2004062563A3 Methods for screening for therapeutic agents that are useful in the treatment of oxytocin and vasopressin-related disorders |
| 12/29/2004 | WO2004061410A3 Serum biomarkers in lung cancer |
| 12/29/2004 | WO2004055241A3 Water electrolysis method and device for determination of hydrogen and oxygen stable isotopic composition |
| 12/29/2004 | WO2004053061A3 Methods of therapy and diagnosis using targeting of cells that express lax |
| 12/29/2004 | WO2004051270A3 Labeling methodology comprising oligopeptides |
| 12/29/2004 | WO2004048599A3 Transporters and ion channels |
| 12/29/2004 | WO2004042072A3 Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry |
| 12/29/2004 | WO2004042009A3 Inhibition of il-17 production |
| 12/29/2004 | WO2004042004A3 Mouse model for autoimmune disorders |
| 12/29/2004 | WO2004040316A3 Diagnostic method for transmissible spongiform encephalopathies (prion diseases) |
| 12/29/2004 | WO2004037996A3 Evaluation of breast cancer states and outcomes using gene expression profiles |
| 12/29/2004 | WO2004015072A3 Mrbs as modifiers of the rb pathway and methods of use |
| 12/29/2004 | WO2004008480A3 Quantitative analysis via isotopically differentitated derivatization |
| 12/29/2004 | WO2004008098A3 NON-INVASIVE MEASUREMENT OF pH |
| 12/29/2004 | WO2004005481A3 Methods for identifying modulators of mda-7 mediated apoptosis |
| 12/29/2004 | WO2003093797A3 Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids |
| 12/29/2004 | WO2003086453A8 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |
| 12/29/2004 | WO2003068983A9 Use of the axl receptor for diagnosis and treatment of renal disease |
| 12/29/2004 | WO2003045984A3 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 12/29/2004 | WO2003025568A9 Identification of antigens by xenogenic, allogenic or autologous antibody-mediated precipitation |
| 12/29/2004 | WO2003010336A3 Molecular markers for hepatocellular carcinoma |
| 12/29/2004 | WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 12/29/2004 | WO2000061774A3 Bone morphogenic proteins |
| 12/29/2004 | EP1492043A2 Pharmacophore model generation and use |
| 12/29/2004 | EP1492019A1 Method of forming molecule function network |
| 12/29/2004 | EP1491896A1 Method of judging cardiotoxicity of anthracycline-type anticancer chemical therapeutic by detecting human h-fabp and reagent therefor |
| 12/29/2004 | EP1491895A1 Modulation of osteoblast activity by Fhl2 |
| 12/29/2004 | EP1491893A1 Support for aminated substance fixing |
| 12/29/2004 | EP1491892A1 Test piece for chromatography and process for producing the same |
| 12/29/2004 | EP1491891A1 Blood processing method, blood processing device, method of measuring hemoglobins and device for measuring hemoglobins |
| 12/29/2004 | EP1491890A1 Method of evaluating hair growth-promoting activity |